SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Spectral Medical Inc.
An SI Board Since October 2011
Posts SubjectMarks Bans Symbol
503 11 0 EDTXF
Emcee:  Sultan Type:  Unmoderated
Spectral is a Phase III company seeking U.S. FDA approval for its lead theranostics product for the treatment for severe sepsis and septic shock. Toraymyxin is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. Directed by the Company's Endotoxin Activity Assay (EAA™), the only FDA cleared diagnostic for the risk of developing sepsis. Spectral's EUPHRATES trial is the world's first theranostics trial in the area of sepsis.

Toraymyxin has been approved for therapeutic use in Japan and Europe , and has been used safely and effectively in more than 80,000 patients to date. In March 2009, Spectral obtained the exclusive development and commercial rights in the U.S. for Toraymyxin, and in November 2010, signed an exclusive distribution agreement for this product in Canada . More than 250,000 patients are diagnosed with severe sepsis and septic shock in North America each year, representing a greater than $1 billion market opportunity for Spectral. Spectral is listed on the Toronto Stock Exchange under the symbol SDI.

For further information please visit spectraldx.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
503Overview This agreement outlines the terms between Spectral Medical Inc. and VaSultan-May 22
502Spectral Medical Update as posted on Linkedin Today We’re pleased to share impoSultan-May 13
501Spectral Medical is “fundamentally undervalued”, Paradigm says [graphic] ParadiSultan-May 8
500Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with VantSultan-May 7
499The Tigris Trial and Corporate Update Call Join Chris Seto, Chief Executive OffSultan-May 6
498The TIGRIS Trial is a confirmatory study of Toraymyxin™ PMX Hemoperfusion in addSultan-April 28
497 Spectral Medical Completes Tigris Trial Enrollment 157 patients enrolledTopliSultan-April 16
496Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides CSultan-March 27
495Spectral Medical Provides February Tigris Trial Update 152 patients enrolled TSultan-March 3
494Presented yesterday at#SCCM2025 Read the full abstract buff.lySultan-February 24
493Is Vantive (they hold the distribution contract with Spectral) gearing up to comSultan-February 19
492Vantive Sponsored Webinar: Is Your Septic Shock Toxic? Understanding Endotoxins Sultan-February 5
491Spectral Medical Provides January Tigris Trial Update https://finance.yahoo.comSultan-February 3
490A Blood Purification publication highlights endotoxin activity's role in criSultan-January 23
489Spectral Medical Provides December Tigris Trial Update • 140 patients enrolled Sultan-January 6
488Spectral combining diagnostics with targeted therapy in novel approach to septicSultan-11/13/2024
487China Daily Article Vantive brand to be unveiled at 7th CIIE By Yuan Shenggao |Sultan-11/5/2024
486Carlos Escobar – General Manager, Mexico, Central America, Puerto Rico and CaribSultan-10/25/2024
485Endotoxin, The Phantom Menace of Sepsis youtube.comSultan-10/22/2024
484This led to the realisation that we had a business with around $4.5bn of revenueSultan-10/19/2024
483Spectral Medical Provides September Tigris Trial Update finance.yahoo.comSultan-10/3/2024
482Beaufort steps in mid-study and delivers comprehensive data management, robust sSultan-10/1/2024
481#DYKthat sepsis contributes to more than half of all deaths from infectious diseSultan-9/30/2024
480Spectral Medical Provides August Tigris Trial Update Management provides view Sultan-9/3/2024
479Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment Sultan-8/13/2024
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):